US Stock MarketDetailed Quotes

EGRX Eagle Pharmaceuticals

Watchlist
  • 1.170
  • -0.010-0.85%
15min DelayClose Feb 14 16:00 ET
15.16MMarket Cap1.33P/E (TTM)

Eagle Pharmaceuticals Key Stats

Eagle Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 8, 20232023/Q264.646M / 59.365M--
May 9, 20232023/Q166.305M / 63.287M--
Mar 13, 20232022/Q460.699M / 64.259M--
Nov 7, 20222022/Q365.901M / 62.077M--
Aug 9, 20222022/Q274.136M / 116.886M--
DatePeriodRevenue/EstimateEarnings Call
Aug 8, 20232023/Q264.646M / 59.365M--
May 9, 20232023/Q166.305M / 63.287M--
Mar 13, 20232022/Q460.699M / 64.259M--
Nov 7, 20222022/Q365.901M / 62.077M--
Aug 9, 20222022/Q274.136M / 116.886M--

Unlock Free Earnings Estimates

Eagle Pharmaceuticals Earnings Reports

Read more

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More